EHRA Premium Access

Atrial fibrillation (AF) in HFrEF, HFmrEF and HFpEF: does it make any difference?

Event: EHRA 2022
Topic: Heart Failure in Atrial Fibrillation
Session type: Symposium
Date: 3 April 2022
Time: 18:05 - 19:05

Congress Session

Become an EHRA member to access this resource

Become a member

Already a member? Sign in

5 presentations in this session

AF in HFrEF, HFmrEF and HFpEF: does it make any difference?

Speaker: Professor R. De Boer (Groningen, NL)
Thumbnail

SGLT2 blockers in AF: the best AAD ever?

Speaker: Professor F. Ruschitzka (Zurich, CH)
Thumbnail

Insights from the Castle AF: why was it positive?

Speaker: Professor N. Marrouche (New Orleans, US)
Thumbnail

The future of AF ablation in heart failure.

Speaker: Professor D. Gupta (Liverpool, GB)
Thumbnail

Atrial Fibrillation (AF) in HFrEF, HFmrEF and HFpEF: does it make any difference? - discussion.

Thumbnail

4 speakers from this session

Professor Rudolf De Boer

University Medical Centre Groningen, Groningen (Netherlands (The))
42 presentations
1 follower

Professor Frank Ruschitzka

University Heart Center, Zurich (Switzerland)
82 presentations
4 followers

Professor Nassir Marrouche

Tulane University, New Orleans (United States of America)
22 presentations
0 follower

Professor Dhiraj Gupta

Liverpool Heart and Chest Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)
17 presentations
0 follower

Related content

ESC Premium Access

Myocarditis associated with COVID vaccines

4 December 2021

ESC Premium Access

Current controversies in antithrombotic therapy

3 December 2021

This platform is supported by

logo Novo Nordisk